GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Target Group Inc (OTCPK:CBDY) » Definitions » ROE %

Target Group (Target Group) ROE % : 0.00% (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Target Group ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Target Group's annualized net income for the quarter that ended in Mar. 2024 was $-0.77 Mil. Target Group's average Total Stockholders Equity over the quarter that ended in Mar. 2024 was $-7.02 Mil. Therefore, Target Group's annualized ROE % for the quarter that ended in Mar. 2024 was N/A%.

The historical rank and industry rank for Target Group's ROE % or its related term are showing as below:

CBDY' s ROE % Range Over the Past 10 Years
Min: -5279.1   Med: -293.56   Max: Negative Equity
Current: Negative Equity

During the past 11 years, Target Group's highest ROE % was Negative Equity%. The lowest was -5,279.10%. And the median was -293.56%.

CBDY's ROE % is ranked better than
99.9% of 997 companies
in the Drug Manufacturers industry
Industry Median: 4.25 vs CBDY: Negative Equity

Target Group ROE % Historical Data

The historical data trend for Target Group's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Target Group ROE % Chart

Target Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -290.71 -5,279.10 Negative Equity - -

Target Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - Negative Equity - - -

Competitive Comparison of Target Group's ROE %

For the Drug Manufacturers - Specialty & Generic subindustry, Target Group's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Target Group's ROE % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Target Group's ROE % distribution charts can be found below:

* The bar in red indicates where Target Group's ROE % falls into.



Target Group ROE % Calculation

Target Group's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-0.324/( (-6.56+-6.973)/ 2 )
=-0.324/-6.7665
=N/A %

Target Group's annualized ROE % for the quarter that ended in Mar. 2024 is calculated as

ROE %=Net Income (Q: Mar. 2024 )/( (Total Stockholders Equity (Q: Dec. 2023 )+Total Stockholders Equity (Q: Mar. 2024 ))/ count )
=-0.772/( (-6.973+-7.073)/ 2 )
=-0.772/-7.023
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2024) net income data. ROE % is displayed in the 30-year financial page.

* Note that if the average Total Stockholders Equity is zero or negative, then ROE % would be considered meaningless and hence not be calculated.


Target Group  (OTCPK:CBDY) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=-0.772/-7.023
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-0.772 / 7.68)*(7.68 / 7.956)*(7.956 / -7.023)
=Net Margin %*Asset Turnover*Equity Multiplier
=-10.05 %*0.9653*N/A
=ROA %*Equity Multiplier
=-9.7 %*N/A
=N/A %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=-0.772/-7.023
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-0.772 / -0.772) * (-0.772 / 0.48) * (0.48 / 7.68) * (7.68 / 7.956) * (7.956 / -7.023)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1 * -1.6083 * 6.25 % * 0.9653 * N/A
=N/A %

Note: The net income data used here is four times the quarterly (Mar. 2024) net income data. The Revenue data used here is four times the quarterly (Mar. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Target Group ROE % Related Terms

Thank you for viewing the detailed overview of Target Group's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Target Group (Target Group) Business Description

Traded in Other Exchanges
N/A
Address
20 Hempstead Drive, Hamilton, ON, CAN, L8W 2E7
Target Group Inc is engaged in the cultivation, processing, and distribution of curated cannabis products for the adult-use medical and recreational cannabis market in Canada. The company generates revenue from the sale of Wisp vaporizer and pod units.
Executives
Barry Alan Katzman director 36 ADDISON DRIVE, ST. CATHERINES A6 L2S 4B7
Anthony Carlo Zarcone director 564 NORTH SHORE BLVD., BURLINGTON A6 L7T 1X2
Frank Michael Monte director 18 BRAESIDE SQ, MARKHAM A6 L3R 0A5
Saul Niddam director 42 HEATHVIEW AVE, NORTH YORK A6 M2K 2C1
Azmatali Mehrali officer: CFO 134 BRIDGEPOINTE COURT, AURORA A6 L4H 3H8
Alexander Starr director, 10 percent owner, officer: President 1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
Rubin Schindermann director, 10 percent owner, officer: CEO 1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
Weinstein Family (2015) Trust 10 percent owner 52 RIDOUT STREET EAST, TILLSONBURG A6 N4G 2E3
Chess Supersite Inc. (canada) 10 percent owner 1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
Nava Starr other: See Remarks 1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
James M Cassidy director, 10 percent owner, officer: president 215 APOLENA AVENUE, NEWPORT BEACH CA 92662
James K Mckillop director, 10 percent owner, officer: vice president 9454 WILSHIRE BOULEVARD, SUITE 612, BEVERLY HILLS CA 90212

Target Group (Target Group) Headlines

From GuruFocus